CAS 1562066-98-1

Formula: C22H30Cl2N4O6

InChI: InChI=1S/C22H28N4O6.2ClH/c1-25(2,31)11-9-23-13-5-6-14(24-10-12-26(3,4)32)18-17(13)21(29)19-15(27)7-8-16(28)20(19)22(18)30;;/h5-8,23-24,27-28H,9-12H2,1-4H3;2*1H/i1D3,2D3,3D3,4D3;;

InChI key: SBWCPHUXRZRTDP-BHITWGRESA-N

SMILES: [2H]C([2H])([2H])[N+](CCNC1=C2C(=C(C=C1)NCC[N+](C([2H])([2H])[2H])(C([2H])([2H])[2H])[O-])C(=O)C3=C(C=CC(=C3C2=O)O)O)(C([2H])([2H])[2H])[O-].Cl.Cl

Banoxantrone-d12 (dihydrochloride)

CAS: 1562066-98-1

Banoxantrone-d12 (dihydrochloride)

Formula: C₂₂H₁₈Cl₂D₁₂N₄O₆

Purity: 95.03%

Molecular weight: 529.48

Ref: 54-DE2307

Banoxantrone-d12 (dihydrochloride)

CAS: 1562066-98-1

Purity: 95.03%

Ref: IN-DA01EOOZ

Banoxantrone-D12 dihydrochloride

CAS: 1562066-98-1

Banoxantrone D12, a deuterium-labeled version, transforms into DNA-binding topoisomerase II inhibitor AQ4 upon reduction.

Formula: C₂₂H₃₀Cl₂N₄O₆

Purity: 98%

Color and Shape: Solid

Molecular weight: 529.48

Ref: TM-T19201

Banoxantrone d12 dihydrochloride

CAS: 1562066-98-1

Banoxantrone is a drug that inhibits the growth of some cancer cells. It binds to the peptide receptors on the cell surface, which blocks the ligand-receptor interaction and prevents the activation of protein kinase A. Banoxantrone is also an activator of tyrosine kinase and has been used as a research tool in pharmacology, cell biology, and biochemistry. This drug has been used as an antibody labeling reagent for peptides. Banoxantrone is soluble in water and has a molecular weight of 456.6 g/mol.

Formula: C₂₂H₃₀Cl₂N₄O₆

Purity: Min. 95%

Molecular weight: 529.5 g/mol

Ref: 3D-MMC06698